Genetic Epidemiology and Antimicrobial Susceptibilities of Carbapenem-Resistant Pseudomonas aeruginosa Isolates from a Multicenter Study in Korea
Tark Kim, Yoon-Kyoung Hong, Seonghee Park, Jongtak Jung, Oh‐Hyun Cho, Hee Bong Shin, Tae Youn Choi, Young Jin Choi, Mi‐Na Kim, Yong Pil Chong
IF 2.9Infection and Chemotherapy
초록
ST235 (7 isolates, 11.1%). Overall susceptibility to ceftazidime/avibactam was only 17.5%, and none of the carbapenemase-producing isolates were susceptible to it. All ST644 strains were also resistant to aztreonam.